Somatuline P.R.

Medicinal product

(Invented) name

Somatuline P.R.

Active substance (s)

Lanreotidas

Strength

30 mg

Pharmaceutical form

milteliai ir tirpiklis pailginto atpalaidavimo injekcinei suspensijai

Route (s) of administration

leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

H01CB03, Lanreotide

Marketing authorisation holder

Ipsen Pharma, Prancūzija

Date of authorisation

2000-01-28

Date of renewal

2008-04-07

Documents

Stage

Išregistruotas

Controlled?

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Flakone yra	1 vnt.
Lanreotidas	30 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
7492	12441	1012441	flakonas	flakonas miltelių ir ampulė tirpiklio (2 ml), injekcinis švirkštas ir 2 injekcinės adatos, N1		Receptinis	LT/1/2000/1096/001	Netiekiama	-	-	No	-	-

Stadijos